PRGTX | SGTRX | PRGTX / SGTRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 22 years | - |
Gain YTD | 1.918 | 3.371 | 57% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.55B | 2.58B | 176% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 33.29 | 13.96 | 238% |
Returns for 3 years | 9.64 | 7.73 | 125% |
Returns for 5 years | 20.66 | 54.45 | 38% |
Returns for 10 years | 80.17 | 154.97 | 52% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EGOCX | 17.63 | 0.15 | +0.86% |
Allspring Large Cap Core C | |||
JEMOX | 30.84 | 0.17 | +0.55% |
JPMorgan Emerging Markets Equity R5 | |||
BEOIX | 8.21 | N/A | N/A |
Barrow Hanley Concentrated EM ESG Opps I | |||
ARIIX | 9.97 | -0.02 | -0.20% |
AB Global Real Estate Investment II I | |||
PHLQX | 43.75 | -0.45 | -1.02% |
PGIM Jennison Health Sciences R6 |